To Assess the Predictive Value of D-dimer Level on the Occurrence of Cardiovascular Events

Global Study to Assess the Safety and Effectiveness of Edoxaban (DU-176b) vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation

NCT00781391 ·Status: COMPLETED ·Phase: PHASE3

Glomerular Filtration Rate-Estimating Equations During Use of Direct Oral Anticoagulants in Elderly Patients

NCT02964546 ·Status: TERMINATED

Dabigatran Adherence Pilot Intervention for Patients With Atrial Fibrillation

NCT01578044 ·Status: COMPLETED ·Phase: NA

DU-176b Phase 2 Dose Finding Study in Subjects With Non-valvular Atrial Fibrillation

NCT00806624 ·Status: COMPLETED ·Phase: PHASE2

Value of D-dimer Combined With Other Thrombus Molecular Markers in Risk Assessment of VTE in Hospitalized Patients

NCT05515549 ·Status: UNKNOWN

Effect of Tinzaparin on Inflammatory Biomarkers During the Acute Phase of Deep Vein Thrombosis

NCT04741464 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Clinical and Laboratory Predictors Associated With Stroke or Systemic Embolism in Low Risk Atrial Fibrillation Patients

NCT03147911 ·Status: COMPLETED

Specific Anti Factor Xa Activity Dosage to Enhance Detection of Nonadherence in Atrial Fibrillation Patients

NCT02925247 ·Status: COMPLETED ·Phase: NA

Echo Doppler (ED )Score and D-dimer (DD) Level in the Evaluation of VTE Recurrence After Anticoagulant Treatment Cessation

NCT00860106 ·Status: COMPLETED ·Phase: PHASE4

A Study to Assess the Safety of a Potential New Drug in Comparison to the Standard Practice of Dosing With Warfarin for Non-valvular Atrial Fibrillation

NCT00504556 ·Status: COMPLETED ·Phase: PHASE2

Pleotropic Effect of New Oral Anticoagulants

NCT02544932 ·Status: UNKNOWN ·Phase: PHASE3

D-dimer to Select Patients With First Unprovoked Venous Thromboembolism Who Can Have Anticoagulants Stopped at 3 Months

NCT00720915 ·Status: COMPLETED ·Phase: NA

Anticoagulation Therapy in Non-device-related Intra-cardiac Thrombus

NCT05825573 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Benefit-Risk Of Arterial THrombotic prEvention With Rivaroxaban for Atrial Fibrillation in France

NCT02864758 ·Status: COMPLETED

Cognitive Impairment Related to Atrial Fibrillation Prevention Trial

NCT01994265 ·Status: COMPLETED ·Phase: PHASE4

Predictive Factors for Response to New Oral Anticoagulants in the Treatment of Non-valvular Atrial Fibrillation..

NCT04297150 ·Status: UNKNOWN

Study in Healthy Volunteers of the Reversion by Haemostatic Drugs of the Anticoagulant Effect of New Anti-thrombotics

NCT01210755 ·Status: COMPLETED ·Phase: PHASE4

Comparative Effectiveness and Safety Between Warfarin and Dabigatran

NCT03254134 ·Status: COMPLETED

D-dimer Levels During and After Anticoagulation in Patients With a Previous Venous Thromboembolism: Effects on the Risk of Recurrence

NCT00266045 ·Status: COMPLETED

Effects of Low Molecular Weight Heparin Versus Dabigatran on Platelet Aggregation in Patients With Stable Coronary Artery Disease

NCT02389582 ·Status: COMPLETED ·Phase: PHASE4

Comparative Effectiveness of Oral Anticoagulants

NCT01847547 ·Status: COMPLETED

Use of Dabigatran Etexilate to Prevent Stroke and Thromboembolism

NCT01976507 ·Status: COMPLETED ·Phase: PHASE4

An Observational Cross-sectional Study Evaluating the Use of Re-sources and the Sociodemographic and Clinical Characteristics of Patients Diagnosed With Non-valvular Atrial Fibrillation With a Risk of Stroke or Systemic Embolism on Anticoagulant Therapy and Treated in Primary Care Centers

NCT02559232 ·Status: COMPLETED

Early Versus Late Resumption of Anticoagulation in Patients With Both High Thrombosis Risk and Major HEmoRrhage

NCT02091479 ·Status: TERMINATED ·Phase: PHASE3

An Observational Cross-sectional Study Evaluating the Sociodemographic and Clinical Characteristics of Patients Diagnosed With NVAF With a Risk of Stroke or Systemic Embolism, Who Are on Treatment to Adequately Control Their Coagulation and Treated in Primary Care Centres

NCT02470767 ·Status: COMPLETED